Toxicity of imatinib mesylate imatinib mesylates. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy16

K562 Cells Philadelphia Chromosome Cell Line, Tumor Neoplastic Stem Cells Chromosomes, Human, Pair 9 Cells, Cultured Bone Marrow Myeloid Progenitor Cells Hematopoietic Stem Cells Tumor Cells, Cultured HL-60 Cells Orbit Stromal Cells Skin Fibroblasts Cell Line

Organisms2

Mice, Nude Mice, SCID

Diseases36

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Leukemia, Myeloid, Chronic-Phase Blast Crisis Hypereosinophilic Syndrome Gastrointestinal Neoplasms Hypopigmentation Philadelphia Chromosome Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Dermatofibrosarcoma Mastocytosis, Systemic Leukemia, Myeloid, Accelerated Phase Fibromatosis, Aggressive Neoplasm, Residual Lichenoid Eruptions Disease Progression Precursor Cell Lymphoblastic Leukemia-Lymphoma Recurrence Primary Myelofibrosis Scleroderma, Systemic Fibrosis Histiocytoma, Malignant Fibrous Neutropenia Leukemia Neoplasm Recurrence, Local Graves Ophthalmopathy Neoplasms Spinal Cord Neoplasms Chromosome Aberrations Bone Neoplasms Neoplasm Metastasis Peritoneal Neoplasms Pulmonary Fibrosis Brain Neoplasms Nerve Sheath Neoplasms Nausea

Chemicals and Drugs49

Mesylates Benzamides Piperazines Ergoloid Mesylates Pyrimidines Palladium Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Protein Kinase Inhibitors Receptor, Platelet-Derived Growth Factor alpha Proto-Oncogene Proteins c-abl Protein-Tyrosine Kinases Receptor, Platelet-Derived Growth Factor beta Thiazoles Receptors, Platelet-Derived Growth Factor Enzyme Inhibitors Harringtonines Proto-Oncogene Proteins c-sis Pregnatrienes Interferon-alpha Pyrroles mRNA Cleavage and Polyadenylation Factors Hydroxyurea Ketones Platelet-Derived Growth Factor Rifabutin STAT5 Transcription Factor Indoles RNA, Messenger Organic Cation Transporter 1 Furans Stem Cell Factor Cytarabine Oncogene Proteins, Fusion Antigens, CD34 P-Glycoprotein src-Family Kinases Neoplasm Proteins Milk Proteins ATP-Binding Cassette Transporters Pyridines Deoxycytidine Bleomycin Lactams, Macrocyclic Benzoquinones Proto-Oncogene Proteins c-akt Tumor Markers, Biological Deferoxamine

Analytical, Diagnostic and Therapeutic Techniques and Equipment34

Cytogenetic Analysis Treatment Outcome Remission Induction Disease-Free Survival Drug Approval Antineoplastic Combined Chemotherapy Protocols Toxicity Tests Drug Administration Schedule Administration, Oral Survival Analysis Salvage Therapy Survival Rate Treatment Failure Prognosis Reverse Transcriptase Polymerase Chain Reaction Inhibitory Concentration 50 Combined Modality Therapy In Situ Hybridization, Fluorescence Follow-Up Studies Toxicity Tests, Acute Neoadjuvant Therapy Blood Cell Count Immunohistochemistry Transplantation, Homologous Blotting, Western Drug Screening Assays, Antitumor Hematopoietic Stem Cell Transplantation Clinical Trials as Topic DNA Mutational Analysis Kaplan-Meier Estimate Xenograft Model Antitumor Assays Maximum Tolerated Dose Positron-Emission Tomography Retrospective Studies

Phenomena and Processes24

Amination Drug Resistance, Neoplasm Genes, abl Philadelphia Chromosome Dose-Response Relationship, Drug Apoptosis Cell Proliferation Time Factors Mutation Drug Synergism Phosphorylation Gene Expression Regulation, Leukemic Cell Survival Inhibitory Concentration 50 Signal Transduction Chromosomes, Human, Pair 9 Blood Cell Count Cell Division Chromosome Aberrations Gene Expression Regulation, Neoplastic Maximum Tolerated Dose G0 Phase Drug Interactions Down-Regulation

Disciplines and Occupations2

Cytogenetics Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Drug Approval United States Food and Drug Administration

Technology, Industry, Agriculture1

Information Science1

Health Care10

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Treatment Failure United States Food and Drug Administration Follow-Up Studies Clinical Trials as Topic Kaplan-Meier Estimate Retrospective Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care

Mesylates Benzamides Piperazines Ergoloid Mesylates Pyrimidines Amination Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Palladium Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Protein Kinase Inhibitors Leukemia, Myeloid, Chronic-Phase Receptor, Platelet-Derived Growth Factor alpha Drug Resistance, Neoplasm Genes, abl Blast Crisis Hypereosinophilic Syndrome Proto-Oncogene Proteins c-abl Cytogenetic Analysis Protein-Tyrosine Kinases K562 Cells Receptor, Platelet-Derived Growth Factor beta Gastrointestinal Neoplasms Hypopigmentation Treatment Outcome Philadelphia Chromosome Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Remission Induction Thiazoles Dose-Response Relationship, Drug Receptors, Platelet-Derived Growth Factor Dermatofibrosarcoma Enzyme Inhibitors Cell Line, Tumor Mastocytosis, Systemic Disease-Free Survival Drug Approval Leukemia, Myeloid, Accelerated Phase Antineoplastic Combined Chemotherapy Protocols Toxicity Tests Fibromatosis, Aggressive Harringtonines Drug Administration Schedule Apoptosis Proto-Oncogene Proteins c-sis Administration, Oral Pregnatrienes Interferon-alpha Cell Proliferation Time Factors Mutation Survival Analysis Drug Synergism Neoplasm, Residual Phosphorylation Gene Expression Regulation, Leukemic Pyrroles Lichenoid Eruptions mRNA Cleavage and Polyadenylation Factors Salvage Therapy Disease Progression Survival Rate Treatment Failure Prognosis Cytogenetics Precursor Cell Lymphoblastic Leukemia-Lymphoma Cell Survival Reverse Transcriptase Polymerase Chain Reaction Recurrence Hydroxyurea United States Food and Drug Administration Inhibitory Concentration 50 Combined Modality Therapy In Situ Hybridization, Fluorescence Follow-Up Studies Neoplastic Stem Cells Ketones Platelet-Derived Growth Factor Signal Transduction Rifabutin Chromosomes, Human, Pair 9 Primary Myelofibrosis STAT5 Transcription Factor Indoles Toxicity Tests, Acute RNA, Messenger Organic Cation Transporter 1 Furans Stem Cell Factor Scleroderma, Systemic Cytarabine Neoadjuvant Therapy Cells, Cultured Blood Cell Count Immunohistochemistry Bone Marrow Myeloid Progenitor Cells Fibrosis

No FAQ available that match "toxicity of imatinib mesylate imatinib mesylates"